Literature DB >> 25416234

Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes.

Akihiro Hoshino1, Keiko Nomura, Takeru Hamashima, Tomoya Isobe, Masafumi Seki, Mitsuteru Hiwatari, Kenichi Yoshida, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Seishi Ogawa, Junko Takita, Hirokazu Kanegane.   

Abstract

Pediatric anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) usually has a benign clinical course. A small fraction of patients with ALCL develops an aggressive clinical course; however, its etiology remains unclear. Here we report on an ALK-positive ALCL patient, who had complex translocations with TPM3-ALK revealed by RNA sequencing, with a very aggressive clinical course. On admission, the patient had extraordinarily high white blood cell count with double ALK-translocated chromosomes, and subsequently developed a more aggressive transformation with invasion into multiple organs with triple ALK-translocated chromosomes. The aggressive clinical course may have been related to these additional chromosomal aberrations. Our report provides new insights into the clonal evolution in ALCL and suggests the importance of monitoring examinations including fluorescence in situ hybridization analysis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25416234     DOI: 10.1007/s12185-014-1701-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

1.  Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.

Authors:  Alice Fabarius; Armin Leitner; Andreas Hochhaus; Martin C Müller; Benjamin Hanfstein; Claudia Haferlach; Gudrun Göhring; Brigitte Schlegelberger; Martine Jotterand; Andreas Reiter; Susanne Jung-Munkwitz; Ulrike Proetel; Juliana Schwaab; Wolf-Karsten Hofmann; Jörg Schubert; Hermann Einsele; Anthony D Ho; Christiane Falge; Lothar Kanz; Andreas Neubauer; Michael Kneba; Frank Stegelmann; Michael Pfreundschuh; Cornelius F Waller; Karsten Spiekermann; Gabriela M Baerlocher; Michael Lauseker; Markus Pfirrmann; Joerg Hasford; Susanne Saussele; Rüdiger Hehlmann
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

2.  Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.

Authors:  Kamel Ait-Tahar; Christine Damm-Welk; Birgit Burkhardt; Martin Zimmermann; Wolfram Klapper; Alfred Reiter; Karen Pulford; Wilhelm Woessmann
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

3.  Integrated molecular analysis of clear-cell renal cell carcinoma.

Authors:  Yusuke Sato; Tetsuichi Yoshizato; Yuichi Shiraishi; Shigekatsu Maekawa; Yusuke Okuno; Takumi Kamura; Teppei Shimamura; Aiko Sato-Otsubo; Genta Nagae; Hiromichi Suzuki; Yasunobu Nagata; Kenichi Yoshida; Ayana Kon; Yutaka Suzuki; Kenichi Chiba; Hiroko Tanaka; Atsushi Niida; Akihiro Fujimoto; Tatsuhiko Tsunoda; Teppei Morikawa; Daichi Maeda; Haruki Kume; Sumio Sugano; Masashi Fukayama; Hiroyuki Aburatani; Masashi Sanada; Satoru Miyano; Yukio Homma; Seishi Ogawa
Journal:  Nat Genet       Date:  2013-06-24       Impact factor: 38.330

4.  Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.

Authors:  Laurence Lamant; Keith McCarthy; Emanuele d'Amore; Wolfram Klapper; Atsuko Nakagawa; Maximo Fraga; Jadwiga Maldyk; Ingrid Simonitsch-Klupp; Ilske Oschlies; Georges Delsol; Audrey Mauguen; Laurence Brugières; Marie-Cécile Le Deley
Journal:  J Clin Oncol       Date:  2011-11-14       Impact factor: 44.544

5.  Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.

Authors:  D Wright; P McKeever; R Carter
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

6.  Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.

Authors:  Gaku Oshikawa; Tetsuya Kurosu; Ayako Arai; Naomi Murakami; Osamu Miura
Journal:  Cancer Genet Cytogenet       Date:  2010-05

7.  Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study.

Authors:  Marie-Cécile Le Deley; Alfred Reiter; Denise Williams; Georges Delsol; Ilske Oschlies; Keith McCarthy; Martin Zimmermann; Laurence Brugières
Journal:  Blood       Date:  2007-10-23       Impact factor: 22.113

8.  Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Authors:  Yael P Mossé; Megan S Lim; Stephan D Voss; Keith Wilner; Katherine Ruffner; Julie Laliberte; Delphine Rolland; Frank M Balis; John M Maris; Brenda J Weigel; Ashish M Ingle; Charlotte Ahern; Peter C Adamson; Susan M Blaney
Journal:  Lancet Oncol       Date:  2013-04-16       Impact factor: 41.316

Review 9.  The anaplastic lymphoma kinase in the pathogenesis of cancer.

Authors:  Roberto Chiarle; Claudia Voena; Chiara Ambrogio; Roberto Piva; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

Review 10.  Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.

Authors:  Jacqueline T Nguyen; Michael R Condron; Nghia D Nguyen; Jitakshi De; L Jeffrey Medeiros; Anthony Padula
Journal:  Pathol Int       Date:  2009-05       Impact factor: 2.534

View more
  3 in total

1.  Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.

Authors:  Jo-Anne van der Krogt; Marlies Vanden Bempt; Julio Finalet Ferreiro; Nicole Mentens; Kris Jacobs; Ursula Pluys; Kathleen Doms; Ellen Geerdens; Anne Uyttebroeck; Pascal Pierre; Lucienne Michaux; Timothy Devos; Peter Vandenberghe; Thomas Tousseyn; Jan Cools; Iwona Wlodarska
Journal:  Haematologica       Date:  2017-06-28       Impact factor: 9.941

2.  Is percutaneous computed tomography-guided biopsy sufficient to establish indolent lymphoma transformation?

Authors:  Petr Dvorak; Petr Hoffmann; Martin Simkovic; Jiri Jandura; Marketa Nova
Journal:  Arch Med Sci       Date:  2018-12-31       Impact factor: 3.318

Review 3.  ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review.

Authors:  Jing Yang; Lei Dong; Hong Du; Xiu-Bo Li; Yan-Xiao Liang; Guo-Rong Liu
Journal:  Diagn Pathol       Date:  2019-10-18       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.